Lipid Market Size, Share & Trends Analysis Report By Application (Pharmaceutical, Food & Beverage), By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Region, And Segment Forecasts, 2023 - 2030

Lipid Market Size, Share & Trends Analysis Report By Application (Pharmaceutical, Food & Beverage), By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Region, And Segment Forecasts, 2023 - 2030

Lipid Market Growth & Trends

The global lipid market size is expected to reach USD 23.31 billion by 2030, registering a CAGR of 6.9% over the forecast period, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of products including dietary supplements, functional foods, functional beverages, pharmaceuticals, and more. In addition, increasing demand for lipids in the formulation of vaccines for COVID-19 has further escalated the industry growth. Lipid nanoparticles have high demand due to their wide usage in the pharmaceutical industry as a result of their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells.

Population growth in Asia Pacific has been a key factor for the steady growth of various application industries in the region. Rising consumption of consumer products, healthcare products, foods & beverages, etc. has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Inc., BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region. The increasing consumption of beverages in China also supports regional growth. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health.

The easy availability of sources, such as plants and animals, has resulted in an increased number of suppliers of raw materials, thereby boosting the region’s growth. However, this results in intense competition in the market, which leads to an inconsistency in prices as well as the availability of raw materials. The pandemic has had a positive impact on market growth. It has also augmented the demand for dietary supplements and medicines. Furthermore, product consumption in the pharmaceuticals industry, particularly for the formulation of COVID-19 vaccines, enhanced its demand during the pandemic.

Lipid Market Report Highlights

  • Triglycerides will be the fastest-growing product segment from 2023 to 2030 on account of the growing product consumption in the production of nutritional foods, dietary supplements, pharmaceuticals, and more
  • The food & beverages application segment will register the fastest CAGR from 2023 to 2030 owing to the increasing consumption of food on the account of the rising population
  • Asia Pacific will the fastest-growing region from 2023 to 2030due to the increasing consumption of functional foods, dietary supplements, and medicines in countries like China and India
  • The presence of government regulations related to the production and consumption of lipids in different countries, owing to the usage of plants & animals for their production, may hinder the industry growth to some extent
  • The ongoing European geopolitical conflict between Russia and Ukraine has led to a rise in the prices of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third Party Perspective
1.3.5 Primary Research
1.3.6 Primary Sources
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
1.7 Research Scope and Assumptions
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segmental Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Global Lipid market
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Raw Material trends
3.3.2 Manufacturing/Technology TRends
3.3.3 Sales channel analysis
3.4 Supply-Demand Analysis
3.4.1 Supply
3.4.2 Demand
3.5 Regulatory Framework
3.6 Price Trend Analysis, 2018 - 2030
3.7 Market Dynamics
3.7.1 Market Driver Impact Analysis
3.7.1.1 Growing global demand for dietary supplements owing to rising health concerns
3.7.2 Increasing usage of lipids in various applications due to their superior functional properties
3.7.3 Market Restraint Impact Analysis
3.7.3.1 Volatile feedstock prices
3.7.4 Industry Challenges
3.8 Impact of COVID-19 On the Industry
3.9 Impact of Eastern European Geopolitical Conflict On the Industry
3.10 Production Cost Analysis
3.11 Opportunities of Nano lipids in pharmaceutical
3.12 Business Environment Analysis
3.12.1 Porter’s Analysis
3.12.2 PESTEL Analysis
Chapter 4 Lipid Market: Product Estimates & Trend Analysis
4.1 Product Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
4.1.1 Ionizable Lipids
4.1.2 Triglycerides
4.1.3 Sphingolipids
4.1.4 Phospholipids
4.1.5 Others (Neutral Lipids, PEGylated Lipids)
Chapter 5 Lipid Market: Phase Estimates & Trend Analysis
5.1 Phase Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
5.1.1 Clinical Phase
5.1.2 Pre-Clinical Phase
5.1.3 Others
Chapter 6 Lipid Market: Application Estimates & Trend Analysis
6.1 Application Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
6.1.1 Pharmaceuticals
6.1.1.1 Vaccines & Drugs
6.1.1.2 Scientific Research
6.1.2 Nutrition & Supplements
6.1.3 Food & Beverages
6.1.4 Others
Chapter 7 Lipid Market: Regional Estimates & Trend Analysis
7.1 Regional Movement Analysis & Market Share, 2022 & 2030 (Kilotons) (USD Million)
7.1.1 North America
7.1.1.1 U.S.
7.1.1.2 Canada
7.1.1.3 Mexico
7.1.2 Europe
7.1.2.1 Germany
7.1.2.2 U.K.
7.1.2.3 France
7.1.2.4 Spain
7.1.2.5 Italy
7.1.2.6 Belgium
7.1.2.7 Russia
7.1.2.8 Turkey
7.1.3 Asia Pacific
7.1.3.1 China
7.1.3.2 India
7.1.3.3 Japan
7.1.3.4 Australia
7.1.3.5 Indonesia
7.1.3.6 Thailand
7.1.3.7 Philippines
7.1.3.8 Malaysia
7.1.3.9 Vietnam
7.1.3.10 South Korea
7.1.4 Central & South America
7.1.4.1 Brazil
7.1.4.2 Argentina
7.1.4.3 Colombia
7.1.5 Middle East & Africa
7.1.5.1 Saudi Arabia
7.1.5.2 South Africa
7.1.5.3 U.A.E.
7.1.5.4 Egypt
7.1.5.5 Nigeria
Chapter 8 Lipid Market - Competitive Landscape
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key innovators, Market leaders, and Emerging players)
8.3 Vendor Landscape
8.3.1 List of Raw Material Suppliers
8.3.2 List of Manufacturers
8.3.3 List of Key Distributors and Channel Partners
8.3.4 List Of Potential EndUsers
8.4 Key Company Market Positioning Analysis, 2022
8.5 Strategic Framework
Chapter 9 Company Profiles
9.1 Evonik Industries AG
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Precision NanoSystems
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic Initiatives
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product Benchmarking
9.3.4 Strategic Initiatives
9.4 Genevant Sciences
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic Initiatives
9.5 Exelead
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product Benchmarking
9.5.4 Strategic Initiatives
9.6 Avanti Polar Lipids
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic Initiatives
9.7 Nippon Fine Chemicals Co. Ltd.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product Benchmarking
9.8 Lipoid GmbH
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Cargill, Incorporated
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 BASF SE
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
9.11 Archer Daniels Midland Company (ADM)
9.11.1 Company Overview
9.11.2 Financial Performance
9.11.3 Product Benchmarking
9.11.4 Strategic Initiatives
9.12 Koninklijke DSM N.V.
9.12.1 Company Overview
9.12.2 Financial Performance
9.12.3 Product Benchmarking
9.12.4 Strategic initiatives
9.13 Kerry Group plc
9.13.1 Company Overview
9.13.2 Financial Performance
9.13.3 Product Benchmarking
9.13.4 Strategic Initiatives
9.14 Nordic Naturals, Inc.
9.14.1 Company Overview
9.14.2 Financial Performance
9.14.3 Product Benchmarking
9.14.4 Strategic initiatives
9.15 Clover Corporation
9.15.1 Company Overview
9.15.2 Financial Performance
9.15.3 Product Benchmarking
9.16 Croda International plc
9.16.1 Company Overview
9.16.2 Financial Performance
9.16.3 Product Benchmarking
9.16.4 Strategic Initiatives
9.17 Lipoid Kosmetik AG
9.17.1 Company Overview
9.17.2 Financial Performance
9.17.3 Product Benchmarking
9.17.4 Strategic initiatives
9.18 Omega Protein Corporation
9.18.1 Company Overview
9.18.2 Financial Performance
9.18.3 Product Benchmarking

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings